Therefore, an increased level of YOD1 might play a tumorigenic role in liver cancer by suppressing Hippo activity, and its inhibitor could be used as a therapeutic tool to reactivate Hippo signaling in liver cancer [155]. The gene discussed is YOD1; the disease is liver cancer.